Methods for treating fatty liver disease, e.g., hepatic steatosis, using peptide fragments of the C-terminal end of glucagon-like peptide-1 (GLP-1), e.g., GLP-1(28-36).
申请公布号
US2013288961(A1)
申请公布日期
2013.10.31
申请号
US201113882825
申请日期
2011.11.02
申请人
HABENER JOEL F.;TOMAS-FALCO EVA;THE GENERAL HOSPITAL CORPORATION
